Woodford Investment Management Ltd (Venture Capital) (extinct)

Woodford Investment Management Ltd (Venture Capital) (extinct)

Woodford Investment Management Ltd (Venture Capital) (extinct)

Overview
Date Founded

2014

Headquarters

9400 Garsington Road,Oxford, Wales OX4 2HN

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

Woodford invests in broad range of sectors and industries located in the London. Firm provides financing for growth stage capital requirements.

Paths to Woodford Investment Management Ltd (Venture Capital)
Potential Connections via
Relationship Science
You
Woodford Investment Management Ltd (Venture Capital)
Recent Transactions
Details Hidden

Advance Publications, Inc. purchases HawKeye 360, Inc. from Allied Minds LLC, Razor's Edge Ventures LLC, Woodford Investment Management Ltd (Venture Capital), Space Angels Holdings, Inc.

Details Hidden

Wacker Chemie AG purchases Nexeon Limited from INVESCO Private Capital, Inc., Touchstone Innovations Investment Management Ltd., Woodford Investment Management Ltd (Venture Capital)

Details Hidden

Mayfair Equity Partners LLP purchases Ultraleap Ltd. from Woodford Investment Management Ltd (Venture Capital)

Transaction Advisors
Escrow Agent

Advised onNeothetics, Inc. purchases Evofem, Inc. from Woodford Investment Management Ltd (Venture Capital)

Investments
Details Hidden

Sensyne Health Holdings Ltd. provides wireless charging technology. It focuses on developing wireless energy devices and wireless sensor networks. The company was founded by Elspeth Drayson, Paul R. Drayson and Manuel Pinuela in April 2014 and is headquartered in London, the United Kingodm.

Details Hidden

Evofem, Inc. develops and markets women's reproductive and personal healthcare products. It offers women's sexual and reproductive health through personal care, disease prevention and contraception products. The company was founded in 2009 and is headquartered in San Diego, CA.

Details Hidden

AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Woodford Investment Management Ltd (Venture Capital). The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Woodford Investment Management Ltd (Venture Capital)'s profile does not indicate a business or promotional relationship of any kind between RelSci and Woodford Investment Management Ltd (Venture Capital).